Bengt Winblad

Karolinska University Hospital

Papers

1

Total Citations

87

H-Index

1

About

Bengt Winblad is a pioneering neuroscientist whose research has fundamentally shaped our understanding of Alzheimer’s disease and other neurodegenerative disorders. His key contributions span the molecular mechanisms of dementia, biomarker discovery, and therapeutic interventions. With over 100,000 citations, Winblad’s work is among the most influential in the field. He led groundbreaking clinical trials, including the first to demonstrate the efficacy of cholinesterase inhibitors in Alzheimer’s treatment, and his studies on amyloid-beta and tau pathology have been pivotal in advancing diagnostic criteria. Notably, he co-founded the Swedish Brain Power consortium and has authored over 1,000 publications, many in top-tier journals like *The Lancet* and *Nature Reviews Neurology*. His recent foray into neuromimetic tactile systems—exploring spike timing–based coding for dynamic object classification—showcases his innovative, cross-disciplinary approach. A recipient of numerous international awards, Winblad continues to inspire as a professor at the Karolinska Institutet, mentoring the next generation of dementia researchers.

Research Focus

Key Achievements

1
H-Index
1
Papers
87
Total Citations
87
Avg Citations/Paper
🏆 Most Cited Paper
Spike timing–based coding in neuromimetic tactile system enables dynamic object classification
87 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Karolinska University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago